Cargando…
Salvage Therapy for Hodgkin’s Lymphoma: A Review of Current Regimens and Outcomes
Relapse/refractory Hodgkin lymphoma patients are still a clinical concern. Indeed, despite more effective first-line chemotherapy regimens and better stratification of unresponsive patients by clinical factors and use of early PET, roughly one-third of such patients need salvage chemotherapy and con...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603406/ https://www.ncbi.nlm.nih.gov/pubmed/33149713 http://dx.doi.org/10.2147/JBM.S250581 |